NCT00896376View on ClinicalTrials.gov

Trastuzumab in Treating Women With Metastatic Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

September 30, 2010

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

OTHER

laboratory biomarker analysis

OTHER

pharmacological study

Trial Locations (1)

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors
lead

Centre Antoine Lacassagne

OTHER

NCT00896376 - Trastuzumab in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter